Xuyang Zhang
North China University of Science and Technology
ORCID: 0000-0001-5084-0225Also affiliated with Army Medical University, Lingnan University, Shanghai Jiao Tong University, Chinese Academy of Sciences, China University of Petroleum, Beijing, National Institute of Fashion Technology, Sir Run Run Shaw Hospital, Research Institute of Petroleum Exploration and Development, Blood Center of Zhejiang Province, China Datang Corporation (China), Southwest Hospital, Shanghai Institute of Optics and Fine Mechanics, Broward Health, Nano Carbon (Poland), Zhejiang University, Broward College, University of Hong Kong
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 2 papers. Top paper: “Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor”.
Shenghui Niu, Shuai Wang, Xiaojing Shi, Siqi Feng, Linna Du +5 more
Elizabeth Stangl, Octav Chipara, Xuyang Zhang, Yu-Hsiang Wu